Govindaraj Sakthivel, Ibegbu Chris, Ali Syed A, Babu Hemalatha, Shanmugasundaram Uma, Villinger Francois, Amara Rama Rao, Velu Vijayakumar
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Division of Microbiology and Immunology, Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA.
AIDS Res Hum Retroviruses. 2025 Mar;41(3):120-123. doi: 10.1089/AID.2024.0043. Epub 2024 Aug 19.
Cytokines are key mediators of immune regulation, orchestrate communication between immune cells, and play a pivotal role in shaping the immune landscape during chronic infection and cancer. The therapeutic potential of IL-15/IL-15Rα and IL-12 has been explored individually in various immunotherapeutic strategies, though not as a combination. Therefore, we investigated whether the combination of IL-15/IL-15Rα and IL-12 treatment would enhance the potency and quality of either NK cells, SIV-specific CD8 T cells, or both, compared with single cytokine treatment. Our findings reveal that IL-15/IL-15Rα and IL-15/IL-15Rα plus IL-12 treatment results in an expansion of functional CD8 T cells and NK cells from uninfected and chronically infected macaques with simian/human immunodeficiency virus. Additionally, the cytokine combination significantly reduced CCR5 expression on total CD4 T cells, limiting the number of viral targets. This study supports the potential utilization of combined IL-15/IL-15Rα plus IL-12 treatment for chronic viral infections and cancer.
细胞因子是免疫调节的关键介质,协调免疫细胞之间的通讯,并在慢性感染和癌症期间塑造免疫格局方面发挥关键作用。IL-15/IL-15Rα和IL-12的治疗潜力已在各种免疫治疗策略中单独进行了探索,但未作为组合进行研究。因此,我们研究了与单一细胞因子治疗相比,IL-15/IL-15Rα和IL-12联合治疗是否会增强NK细胞、SIV特异性CD8 T细胞或两者的效力和质量。我们的研究结果表明,IL-15/IL-15Rα以及IL-15/IL-15Rα加IL-12治疗可使未感染和慢性感染猿猴/人类免疫缺陷病毒的猕猴体内的功能性CD8 T细胞和NK细胞扩增。此外,细胞因子组合显著降低了总CD4 T细胞上CCR5的表达,限制了病毒靶标的数量。这项研究支持了IL-15/IL-15Rα加IL-12联合治疗在慢性病毒感染和癌症中的潜在应用。